Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107.
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19399-19407. doi: 10.1073/pnas.2004372117. Epub 2020 Jul 27.
The source proteins from which CD8 T cell-activating peptides are derived remain enigmatic. Glycoproteins are particularly challenging in this regard owing to several potential trafficking routes within the cell. By engineering a glycoprotein-derived epitope to contain an N-linked glycosylation site, we determined that optimal CD8 T cell expansion and function were induced by the peptides that are rapidly produced from the exceedingly minor fraction of protein mislocalized to the cytosol. In contrast, peptides derived from the much larger fraction that undergoes translocation and quality control are produced with delayed kinetics and induce suboptimal CD8 T cell responses. This dual system of peptide generation enhances CD8 T cell participation in diversifying both antigenicity and the kinetics of peptide display.
CD8 T 细胞激活肽的来源蛋白仍然是个谜。糖蛋白在这方面特别具有挑战性,因为它们在细胞内有几种潜在的运输途径。通过设计一种糖蛋白衍生的表位,使其包含一个 N 连接的糖基化位点,我们确定,最佳的 CD8 T 细胞扩增和功能是由极少量蛋白错误定位到细胞质中产生的肽诱导的。相比之下,从经历易位和质量控制的大得多的部分衍生的肽的产生具有延迟的动力学,并诱导次优的 CD8 T 细胞反应。这种双重的肽生成系统增强了 CD8 T 细胞参与多样化抗原性和肽展示动力学的能力。